Overcoming NK cell resistance in triple-negative breast cancer via adcc with a humanized anti-CD147 antibody
Abstract Triple-negative breast cancer (TNBC) is an aggressive and clinically challenging subtype defined by the absence of estrogen receptor, progesterone receptor, and HER2 amplification, resulting in poor prognosis and limited therapeutic options. Targeting alternative molecular pathways is urgen...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2025-10-01
|
| Edice: | Cancer Immunology, Immunotherapy |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s00262-025-04203-z |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
